Recurrent Skin Cancer: Clinical Trials

11 trials for Recurrent Skin Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 terminated, 2 withdrawn. 7 Phase 2, 3 Phase 1, 2 Not applicable, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 4, Terminated 2, Withdrawn 1
Phase 13Completed 2, Withdrawn 1
Not applicable2Completed 1, Withdrawn 1
Early Phase 11Completed 1

Follow Recurrent Skin Cancer: new trials by email Literature Review of Recurrent Skin Cancer trials Research Report on Recurrent Skin Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Buparlisib, Sonidegib - Carcinoma, Basal Cell, Recurrent Skin Cancer
Phase 2TerminatedAnne Chang102015-02-012019-01-29
Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer
cetuximab, laboratory biomarker analysis - Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin
Not applicableCompletedRutgers, The State University of New Jersey152015-01-302023-12-20
Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma
arsenic trioxide - Basal Cell Carcinoma of the Skin, Recurrent Skin Cancer
Phase 1 / Phase 2CompletedStanford University52013-04-012018-06-08
Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin
Capecitabine - Squamous Cell Carcinoma of the Skin, Recurrent Skin Cancer
Phase 2TerminatedStanford University22013-03-012018-04-12
Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)
vismodegib, Mohs surgery - Basal Cell Carcinoma of the Skin, Recurrent Skin Cancer
Early Phase 1CompletedStanford University152012-06-012017-12-08
Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma
isolated limb perfusion, melphalan, quality-of-life assessment - Basal Cell Carcinoma of the Skin, Eccrine Carcinoma of the Skin
Not applicableWithdrawnAlbert Einstein College of Medicine2012-04-012015-07-23
Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)
erlotinib hydrochloride, linsitinib, placebo - Recurrent Skin Cancer, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity
Phase 1 / Phase 2WithdrawnOHSU Knight Cancer Institute2011-12-012014-11-19
Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer
methyl-5-aminolevulinate hydrochloride cream, photodynamic therapy, laser therapy - Basal Cell Carcinoma of the Skin, Pain
Phase 1CompletedRoswell Park Cancer Institute212011-03-012014-09-29
Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia
dasatinib, laboratory biomarker analysis - Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin
Phase 2CompletedNational Cancer Institute (NCI)72007-11-012015-06-18
Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer
Gefitinib, Radiotherapy, Conventional surgery - Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin
Phase 2CompletedNational Cancer Institute (NCI)232005-03-012019-08-30
T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant
liposomal T4N5 lotion, placebo, laboratory biomarker analysis - Actinic Keratosis, Basal Cell Carcinoma of the Skin
Phase 2CompletedNational Cancer Institute (NCI)1002004-03-012015-12-04

Narrower conditions

Skin Neoplasms (11)  ·  Carcinoma, Basal Cell (6)  ·  Basal Cell Nevus Syndrome (1)  ·  Keratosis, Actinic (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Melanoma (1)  ·  Pain (1)  ·  Sarcoma (1)

Broader conditions

Neoplasms (11)  ·  Neoplasms by Site (11)  ·  Skin Diseases (11)  ·  Skin and Connective Tissue Diseases (11)  ·  Neoplasms by Histologic Type (7)  ·  Carcinoma (6)  ·  Neoplasms, Basal Cell (6)  ·  Neoplasms, Glandular and Epithelial (6)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Abnormalities, Multiple (1)  ·  Bone Cysts (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Developmental (1)  ·  Chronic Disease (1)  ·  Congenital Abnormalities (1)

Interventions

Radiation (2)  ·  Radiotherapy (2)  ·  1-phenyl-3,3-dimethyltriazene (1)  ·  3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol (1)  ·  Arsenic Trioxide (1)  ·  Capecitabine (1)  ·  Cetuximab (1)  ·  Congresses as Topic (1)  ·  Dasatinib (1)  ·  Deoxyribonuclease (Pyrimidine Dimer) (1)  ·  Erlotinib Hydrochloride (1)  ·  Gefitinib (1)  ·  HhAntag691 (1)  ·  Laser Therapy (1)  ·  Melphalan (1)

Sponsors

National Cancer Institute (NCI) (3)  ·  Stanford University (3)  ·  Albert Einstein College of Medicine (1)  ·  Anne Chang (1)  ·  OHSU Knight Cancer Institute (1)  ·  Roswell Park Cancer Institute (1)  ·  Rutgers, The State University of New Jersey (1)

Countries

United States (11)

Top investigators

Adam Berger, MD (1)  ·  Alexander Colevas (1)  ·  Anne Lynn Chang, MD (1)  ·  Craig Elmets (1)  ·  Ilene L Rothman, MD (1)  ·  Jean Tang (1)  ·  Jean Tang, MD (1)  ·  Katia Papalezova (1)  ·  Neil Gross (1)  ·  Randal Weber (1)  ·  Thomas Olencki (1)

Results publications

PMID 24929884, PMID 29175429

NIH funding

N01CM00070 (1), P30CA013330 (1), P30CA016058 (1), P30CA072720 (1)